Abstract
We hereby report a short case of 71-year-old gentleman who developed ST segment elevation myocardial infarction shortly after starting the infusion of liposomal amphotericin B for disseminated histoplasmosis. We also discuss the novel pathogenesis of specific liposomal component of amphotericin B that contributed to the acute cardiopulmonary compromise in our patient leading to subsequent myocardial infarction.
Original language | English (US) |
---|---|
Pages (from-to) | e157-e158 |
Journal | American Journal of Therapeutics |
Volume | 18 |
Issue number | 5 |
DOIs | |
State | Published - Sep 1 2011 |
Externally published | Yes |
Keywords
- hypotension
- liposomal amphotericin B
- myocardial infarction
- pseudoallergy
ASJC Scopus subject areas
- Pharmacology
- Pharmacology (medical)